149 related articles for article (PubMed ID: 32305064)
1. Eosinophilic colitis in a boy with a novel XIAP mutation: a case report.
Tang J; Zhou X; Wang L; Hu G; Zheng B; Wang C; Lu Y; Jin Y; Guo H; Liu Z
BMC Pediatr; 2020 Apr; 20(1):171. PubMed ID: 32305064
[TBL] [Abstract][Full Text] [Related]
2. Risk-factors Associated With Poor Outcomes in VEO-IBD Secondary to XIAP Deficiency: A Case Report and Literature Review.
Lekbua A; Ouahed J; O'Connell AE; Kahn SA; Goldsmith JD; Imamura T; Duncan CN; Kelsen JR; Worthey E; Snapper SB; Softic S
J Pediatr Gastroenterol Nutr; 2019 Jul; 69(1):e13-e18. PubMed ID: 31232887
[TBL] [Abstract][Full Text] [Related]
3. [X-linked inhibitor of apoptosis deficiency manifested as Crohn's disease: a case report and literature review].
Xu LJ; Luo YY; Yu JD; Lou JG; Fang YH; Chen J
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):43-47. PubMed ID: 29342997
[No Abstract] [Full Text] [Related]
4. Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.
Ono S; Okano T; Hoshino A; Yanagimachi M; Hamamoto K; Nakazawa Y; Imamura T; Onuma M; Niizuma H; Sasahara Y; Tsujimoto H; Wada T; Kunisaki R; Takagi M; Imai K; Morio T; Kanegane H
J Clin Immunol; 2017 Jan; 37(1):85-91. PubMed ID: 27815752
[TBL] [Abstract][Full Text] [Related]
5. Phenotype, genotype, treatment, and survival outcomes in patients with X-linked inhibitor of apoptosis deficiency.
Yang L; Booth C; Speckmann C; Seidel MG; Worth AJJ; Kindle G; Lankester AC; Grimbacher B; ; Gennery AR; Seppanen MRJ; Morris EC; Burns SO
J Allergy Clin Immunol; 2022 Aug; 150(2):456-466. PubMed ID: 34920033
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report.
Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y
BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347
[TBL] [Abstract][Full Text] [Related]
7. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.
Speckmann C; Lehmberg K; Albert MH; Damgaard RB; Fritsch M; Gyrd-Hansen M; Rensing-Ehl A; Vraetz T; Grimbacher B; Salzer U; Fuchs I; Ufheil H; Belohradsky BH; Hassan A; Cale CM; Elawad M; Strahm B; Schibli S; Lauten M; Kohl M; Meerpohl JJ; Rodeck B; Kolb R; Eberl W; Soerensen J; von Bernuth H; Lorenz M; Schwarz K; Zur Stadt U; Ehl S
Clin Immunol; 2013 Oct; 149(1):133-41. PubMed ID: 23973892
[TBL] [Abstract][Full Text] [Related]
8. Absent X-linked inhibitor of apoptosis protein expression in T cell blasts and causal mutations including non-coding deletion.
Abdrabou SSMA; Toita N; Ichihara S; Tozawa Y; Takahashi M; Fujiwara SI; Ashida T; Ohara O; Ariga T; Manabe A; Konno M; Yamada M
Pediatr Int; 2022 Jan; 64(1):e14892. PubMed ID: 34145698
[TBL] [Abstract][Full Text] [Related]
9. Successful allogeneic hematopoietic stem cell transplantation in a boy with X-linked inhibitor of apoptosis deficiency presenting with hemophagocytic lymphohistiocytosis: A case report.
Jiang MY; Guo X; Sun SW; Li Q; Zhu YP
Exp Ther Med; 2016 Sep; 12(3):1341-1344. PubMed ID: 27602064
[TBL] [Abstract][Full Text] [Related]
10. XIAP deficiency syndrome in humans.
Latour S; Aguilar C
Semin Cell Dev Biol; 2015 Mar; 39():115-23. PubMed ID: 25666262
[TBL] [Abstract][Full Text] [Related]
11. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
Marsh RA; Madden L; Kitchen BJ; Mody R; McClimon B; Jordan MB; Bleesing JJ; Zhang K; Filipovich AH
Blood; 2010 Aug; 116(7):1079-82. PubMed ID: 20489057
[TBL] [Abstract][Full Text] [Related]
12. Clinical phenotype and functional analysis of a rare XIAP/BIRC4 mutation.
Vieth S; Ammann S; Schwarz K; Härtel C; Schultz C; Lehmberg K; Lauten M
Klin Padiatr; 2013 Nov; 225(6):343-6. PubMed ID: 24166087
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency.
Girardelli M; Arrigo S; Barabino A; Loganes C; Morreale G; Crovella S; Tommasini A; Bianco AM
BMC Pediatr; 2015 Dec; 15():208. PubMed ID: 26671016
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency.
Ono S; Takeshita K; Kiridoshi Y; Kato M; Kamiya T; Hoshino A; Yanagimachi M; Arai K; Takeuchi I; Toita N; Imamura T; Sasahara Y; Sugita J; Hamamoto K; Takeuchi M; Saito S; Onuma M; Tsujimoto H; Yasui M; Taga T; Arakawa Y; Mitani Y; Yamamoto N; Imai K; Suda W; Hattori M; Ohara O; Morio T; Honda K; Kanegane H
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3767-3780. PubMed ID: 34246792
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic characteristics of XIAP deficiency in Japan.
Yang X; Kanegane H; Nishida N; Imamura T; Hamamoto K; Miyashita R; Imai K; Nonoyama S; Sanayama K; Yamaide A; Kato F; Nagai K; Ishii E; van Zelm MC; Latour S; Zhao XD; Miyawaki T
J Clin Immunol; 2012 Jun; 32(3):411-20. PubMed ID: 22228567
[TBL] [Abstract][Full Text] [Related]
16. X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis.
Steele CL; Doré M; Ammann S; Loughrey M; Montero A; Burns SO; Morris EC; Gaspar B; Gilmour K; Bibi S; Shendi H; Devlin L; Speckmann C; Edgar DM
J Clin Immunol; 2016 Oct; 36(7):733-8. PubMed ID: 27492372
[TBL] [Abstract][Full Text] [Related]
17. How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.
Nielsen OH; LaCasse EC
Genet Med; 2017 Feb; 19(2):133-143. PubMed ID: 27416006
[TBL] [Abstract][Full Text] [Related]
18. Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
Topal J; Panchal N; Barroeta A; Roppelt A; Mudde A; Gaspar HB; Thrasher AJ; Houghton BC; Booth C
J Clin Immunol; 2023 Feb; 43(2):440-451. PubMed ID: 36329240
[TBL] [Abstract][Full Text] [Related]
19. A female patient with incomplete hemophagocytic lymphohistiocytosis caused by a heterozygous XIAP mutation associated with non-random X-chromosome inactivation skewed towards the wild-type XIAP allele.
Yang X; Hoshino A; Taga T; Kunitsu T; Ikeda Y; Yasumi T; Yoshida K; Wada T; Miyake K; Kubota T; Okuno Y; Muramatsu H; Adachi Y; Miyano S; Ogawa S; Kojima S; Kanegane H
J Clin Immunol; 2015 Apr; 35(3):244-8. PubMed ID: 25744037
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Our Understanding of XIAP Deficiency.
Mudde ACA; Booth C; Marsh RA
Front Pediatr; 2021; 9():660520. PubMed ID: 34222142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
